Molecular characterization of a purified 5-HT4 receptor: a structural basis for drug efficacy.
about
Beta-arrestin1 phosphorylation by GRK5 regulates G protein-independent 5-HT4 receptor signallingLigand-specific regulation of the extracellular surface of a G-protein-coupled receptorUnderstanding functional residues of the cannabinoid CB1.High-level production, solubilization and purification of synthetic human GPCR chemokine receptors CCR5, CCR3, CXCR4 and CX3CR1Towards structural systems pharmacology to study complex diseases and personalized medicineActivation of G protein-coupled receptors: beyond two-state models and tertiary conformational changes.Diversity of actions of GnRHs mediated by ligand-induced selective signalingIsotopic labeling of mammalian G protein-coupled receptors heterologously expressed in Caenorhabditis elegans.Forced unbinding of GPR17 ligands from wild type and R255I mutant receptor models through a computational approach.GPCR and G proteins: drug efficacy and activation in live cells.Leukotriene BLT2 receptor monomers activate the G(i2) GTP-binding protein more efficiently than dimersLigand-specific conformation of extracellular loop-2 in the angiotensin II type 1 receptor.Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery.The potential for selective pharmacological therapies through biased receptor signalingIdentification of the GPR55 antagonist binding site using a novel set of high-potency GPR55 selective ligands.Extracellular loop 2 of the free fatty acid receptor 2 mediates allosterism of a phenylacetamide ago-allosteric modulator.Post-translational modifications of the serotonin type 4 receptor heterologously expressed in mouse rod cells5-hydroxytryptamine 4 receptor activation of the extracellular signal-regulated kinase pathway depends on Src activation but not on G protein or beta-arrestin signaling.Complete Reversible Refolding of a G-Protein Coupled Receptor on a Solid Support.Ligands and signaling proteins govern the conformational landscape explored by a G protein-coupled receptorHomology modeling and molecular dynamics simulations of the active state of the nociceptin receptor reveal new insights into agonist binding and activation.Advances in receptor conformation research: the quest for functionally selective conformations focusing on the β2-adrenoceptorStructural genomics and drug discovery.Efficient production of membrane-integrated and detergent-soluble G protein-coupled receptors in Escherichia coli.Human P2Y(6) receptor: molecular modeling leads to the rational design of a novel agonist based on a unique conformational preference.Two arginine-glutamate ionic locks near the extracellular surface of FFAR1 gate receptor activation.Folding scene investigation: membrane proteins.Allosteric modulation of a cannabinoid G protein-coupled receptor: binding site elucidation and relationship to G protein signaling.Lifting the lid on GPCRs: the role of extracellular loops.New concepts in pharmacological efficacy at 7TM receptors: IUPHAR review 2.How ligands and signalling proteins affect G-protein-coupled receptors' conformational landscape.New paradigms in chemokine receptor signal transduction: Moving beyond the two-site model.Biosynthesis, purification, and characterization of a cannabinoid receptor 2 fragment (CB2(271-326)).Systematic analysis of the entire second extracellular loop of the V(1a) vasopressin receptor: key residues, conserved throughout a G-protein-coupled receptor family, identified.Asymmetric conformational changes in a GPCR dimer controlled by G-proteins.High constitutive activity is an intrinsic feature of ghrelin receptor protein: a study with a functional monomeric GHS-R1a receptor reconstituted in lipid discs.In silico characterization of binding mode of CCR8 inhibitor: homology modeling, docking and membrane based MD simulation study.G protein activation by serotonin type 4 receptor dimers: evidence that turning on two protomers is more efficient.An expression and purification system for the biosynthesis of adenosine receptor peptides for biophysical and structural characterization.Modulation of constitutive activity and signaling bias of the ghrelin receptor by conformational constraint in the second extracellular loop.
P2860
Q24321629-55630705-E328-419F-B595-E8135933042CQ27646733-4EA5E44A-4BCE-4F22-8650-C4D2D0CDB63BQ27687653-6BC4D36B-7B86-4ACE-8BEA-F76C7CBA77A3Q28474776-09CF4D16-F1C1-4F71-B2F4-E2A2E640E7EBQ28538838-DEBEEB7A-CF53-4CC3-BAD8-8499F6EBE9EDQ30364526-8699A9FA-A25E-423E-8F35-4669A9984917Q30439870-E2677162-D2A3-4EC5-8A76-C02D2B3E7A6CQ30873611-4CD336ED-903B-40F9-BD04-AFFE4B30D188Q33541287-9F7EF63F-2809-44E5-9001-76ADAB7499D0Q33642442-8ADD9023-08EA-49FB-98F2-B0F8D0981899Q33673636-EC721E76-2211-44FD-A10E-794468C4DA17Q33855316-1A86A044-C815-4338-895F-80FC2797F57EQ33890786-9850823B-7275-4AD6-B33F-157A5BCA3EBDQ34402658-9A8D33F1-3818-4A3C-B03A-EC84B60B81A0Q35052556-4716A1A3-EB18-4401-B5A7-0E427B36BEC7Q35080498-F64BE4F3-2900-47B8-9590-B1C5418B93DAQ35710614-B58653FA-5805-4B77-9FA7-3D99FD766197Q35810546-A1D78763-355D-4440-9478-F2F7440238DCQ35959736-AB2339C2-0B64-45BC-966D-0EDB29848C12Q35991642-D4116D4D-92B2-45AE-9E36-5D81195E8B6FQ36087159-82A77634-5A9A-41DF-81AE-ADB7038C098AQ36342155-A0006DAE-94BC-4CFC-8B5C-EA38B3D9E6A8Q36815339-13F0F311-857E-492E-A1F3-F5E1368F5BF5Q36901637-E92156B5-3F63-4B91-B327-94C2097F2CA2Q36974147-D0C63A33-FB55-48E9-A93D-170B483718BCQ37081904-ED712398-13F3-4099-9FB9-081EFEE6E957Q37373862-E14C1AEB-E829-4829-91CF-BBE74E1C8DCBQ37608491-78D09BCF-1D43-46C8-BDD2-B3273B8D61D7Q37921853-E05DD448-CE6A-4330-8CC6-EEA614274F63Q38044984-C96F0581-3F82-455F-BF1C-821E421908A5Q38077222-C8A04163-6072-40C9-B213-5274D80FD095Q38815332-759BFF0F-7333-44F3-97B6-6F2A4C11B253Q39935967-63AB9A02-D2E9-4AB0-8954-152E25AAAA19Q40150862-FB28C069-AECC-4D76-837C-4C44B2DF0CACQ41093303-2A6EA3DE-B397-4F82-844E-BB7F5829B662Q41226865-0FE0F1FE-7B21-4693-BEE9-B10AE9F164B9Q41533540-219FD7A9-33BA-4D77-8FA8-EBEC8DDF1FC5Q41907669-08183E4A-2327-4978-A66F-D4077C8EA30AQ41913411-6605A9DD-F875-42C8-A5C3-78802148AAD1Q41940041-09DBABA4-7F20-4F05-9491-685AC560B4CE
P2860
Molecular characterization of a purified 5-HT4 receptor: a structural basis for drug efficacy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Molecular characterization of ...... tural basis for drug efficacy.
@en
Molecular characterization of ...... tural basis for drug efficacy.
@nl
type
label
Molecular characterization of ...... tural basis for drug efficacy.
@en
Molecular characterization of ...... tural basis for drug efficacy.
@nl
prefLabel
Molecular characterization of ...... tural basis for drug efficacy.
@en
Molecular characterization of ...... tural basis for drug efficacy.
@nl
P2093
P2860
P356
P1476
Molecular characterization of ...... tural basis for drug efficacy.
@en
P2093
Aimée Martin
Aline Dumuis
Danielle Mesnier
Jean-Louis Banères
Joel Bockaert
Lara Joubert
P2860
P304
20253-20260
P356
10.1074/JBC.M412009200
P407
P577
2005-03-17T00:00:00Z